Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Nortech Systems Incorporated | NSYS | $11.71 | $33.42M | 32.5 | — |
| Context Therapeutics Inc. | CNTX | $0.36 | $33.23M | — | |
| Resverlogix Corp. | RVX.TO | CA$0.10 | CA$32.71M | — | |
| Actinium Pharmaceuticals, Inc. | ATNM | $1.03 | $32.32M | 3.0 | — |
| Rockwell Medical, Inc. | RMTI | $7.99 | $32.18M | — | |
| MIRA Pharmaceuticals, Inc. | MIRA | $0.76 | $32.10M | — | |
| MediPharm Labs Corp. | LABS.TO | CA$0.08 | CA$32.04M | — | |
| Accuray Incorporated | ARAY | $0.27 | $31.87M | — | |
| Quince Therapeutics, Inc. | QNCX | $31.32 | $31.85M | — | |
| Barinthus Biotherapeutics plc | BRNS | $0.76 | $31.00M | — | |
| IGC Pharma, Inc. | IGC | $0.30 | $30.81M | — | |
| 111, Inc. | YI | $3.47 | $30.48M | — | |
| Radiopharm Theranostics Limited | RADX | $2.08 | $30.07M | — | |
| Modular Medical, Inc. | MODD | $3.68 | $30.00M | — | |
| CEL-SCI Corporation | CVM | $1.63 | $28.67M | — | |
| NanoViricides, Inc. | NNVC | $1.12 | $28.59M | — | |
| Evaxion A/S | EVAX | $3.12 | $28.15M | — | |
| Estrella Immunopharma, Inc. | ESLA | $0.65 | $28.11M | — | |
| Cosmos Health Inc. | COSM | $0.27 | $27.49M | — | |
| Optimi Health Corp. | OPTH | $4.78 | $27.34M | — | |
| Polyrizon Ltd. | PLRZ | $11.24 | $26.66M | — | |
| Plus Therapeutics, Inc. | PSTV | $3.84 Aug 7, 2026 | $26.64M | 0.2 | — |
| TScan Therapeutics, Inc. | TCRX | $0.39 | $26.54M | — | |
| ABVC BioPharma, Inc. | ABVC | $0.96 | $25.59M | — | |
| TherapeuticsMD, Inc. Common Stock | TXMD | $2.21 | $25.58M | — | |
| Tvardi Therapeutics, Inc. | TVRD | $1.91 | $25.48M | — | |
| BeyondSpring Inc. | BYSI | $0.62 | $25.42M | — | |
| Atossa Therapeutics, Inc. | ATOS | $2.52 | $25.15M | — | |
| Femasys Inc. | FEMY | $2.98 | $24.96M | — | |
| Lantern Pharma Inc. | LTRN | $1.91 | $24.35M | — | |
| HeartBeam, Inc. | BEAT | $0.43 | $24.05M | — | |
| Biofrontera Inc. | BFRI | $1.61 | $23.91M | — | |
| Aytu BioPharma, Inc. | AYTU | $2.21 | $23.72M | — | |
| Jasper Therapeutics, Inc. | JSPR | $0.71 | $23.58M | — | |
| Lexaria Bioscience Corp. | LEXX | $14.15 | $23.38M | — | |
| GridAI Technologies Corp. | GRDX | $3.25 | $23.18M | — | |
| Palatin Technologies, Inc. | PTN | $12.70 | $22.60M | 115.5 | — |
| Allarity Therapeutics, Inc. | ALLR | $1.42 | $22.59M | — | |
| Cellectar Biosciences, Inc. | CLRB | $2.37 | $22.40M | — | |
| Akari Therapeutics, Plc | AKTX | $11.47 | $22.33M | — | — |
| Sensei Biotherapeutics, Inc. | SNSE | $25.96 Jul 17, 2026 | $22.10M | — | |
| Cytosorbents Corporation | CTSO | $0.35 | $22.00M | — | |
| Cocrystal Pharma, Inc. | COCP | $1.13 | $21.77M | — | |
| Longeveron Inc. | LGVN | $6.81 | $21.71M | — | |
| Retractable Technologies, Inc. | RVP | $0.71 | $21.28M | — | |
| Cerenome, Inc. | CNSY | $2.76 | $20.91M | 1.0 | — |
| Adial Pharmaceuticals, Inc. | ADIL | $7.12 | $20.89M | — | |
| Dyadic International, Inc. | DYAI | $0.52 | $20.84M | — | |
| Quantum BioPharma Ltd. | QNTM | $3.24 | $20.83M | — | |
| Neuphoria Therapeutics Inc. | NEUP | $3.77 | $20.38M | — |
Nortech Systems Incorporated
Healthcare / Medical Devices
- Market Cap
- $33.42M
- P/E
- 32.5
Context Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $33.23M
- P/E
- unprofitable
Resverlogix Corp.
Healthcare / Biotechnology
- Market Cap
- CA$32.71M
- P/E
- unprofitable
Actinium Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $32.32M
- P/E
- 3.0
Rockwell Medical, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $32.18M
- P/E
- unprofitable
MIRA Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $32.10M
- P/E
- unprofitable
MediPharm Labs Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$32.04M
- P/E
- unprofitable
Accuray Incorporated
Healthcare / Medical Devices
- Market Cap
- $31.87M
- P/E
- unprofitable
Quince Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $31.85M
- P/E
- unprofitable
Barinthus Biotherapeutics plc
Healthcare / Biotechnology
- Market Cap
- $31.00M
- P/E
- unprofitable
IGC Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $30.81M
- P/E
- unprofitable
111, Inc.
Healthcare / Medical Distribution
- Market Cap
- $30.48M
- P/E
- unprofitable
Radiopharm Theranostics Limited
Healthcare / Biotechnology
- Market Cap
- $30.07M
- P/E
- unprofitable
Modular Medical, Inc.
Healthcare / Medical Devices
- Market Cap
- $30.00M
- P/E
- unprofitable
CEL-SCI Corporation
Healthcare / Biotechnology
- Market Cap
- $28.67M
- P/E
- unprofitable
NanoViricides, Inc.
Healthcare / Biotechnology
- Market Cap
- $28.59M
- P/E
- unprofitable
Evaxion A/S
Healthcare / Biotechnology
- Market Cap
- $28.15M
- P/E
- unprofitable
Estrella Immunopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $28.11M
- P/E
- unprofitable
Cosmos Health Inc.
Healthcare / Medical Distribution
- Market Cap
- $27.49M
- P/E
- unprofitable
Optimi Health Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $27.34M
- P/E
- unprofitable
Polyrizon Ltd.
Healthcare / Biotechnology
- Market Cap
- $26.66M
- P/E
- unprofitable
Plus Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $26.64M
- P/E
- 0.2
TScan Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $26.54M
- P/E
- unprofitable
ABVC BioPharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $25.59M
- P/E
- unprofitable
TherapeuticsMD, Inc. Common Stock
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $25.58M
- P/E
- unprofitable
Tvardi Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $25.48M
- P/E
- unprofitable
BeyondSpring Inc.
Healthcare / Biotechnology
- Market Cap
- $25.42M
- P/E
- unprofitable
Atossa Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $25.15M
- P/E
- unprofitable
Femasys Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $24.96M
- P/E
- unprofitable
Lantern Pharma Inc.
Healthcare / Biotechnology
- Market Cap
- $24.35M
- P/E
- unprofitable
HeartBeam, Inc.
Healthcare / Health Information Services
- Market Cap
- $24.05M
- P/E
- unprofitable
Biofrontera Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $23.91M
- P/E
- unprofitable
Aytu BioPharma, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $23.72M
- P/E
- unprofitable
Jasper Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $23.58M
- P/E
- unprofitable
Lexaria Bioscience Corp.
Healthcare / Biotechnology
- Market Cap
- $23.38M
- P/E
- unprofitable
GridAI Technologies Corp.
Healthcare / Biotechnology
- Market Cap
- $23.18M
- P/E
- unprofitable
Palatin Technologies, Inc.
Healthcare / Biotechnology
- Market Cap
- $22.60M
- P/E
- 115.5
Allarity Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $22.59M
- P/E
- unprofitable
Cellectar Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $22.40M
- P/E
- unprofitable
Akari Therapeutics, Plc
Healthcare / Biotechnology
- Market Cap
- $22.33M
Sensei Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $22.10M
- P/E
- unprofitable
Cytosorbents Corporation
Healthcare / Medical Devices
- Market Cap
- $22.00M
- P/E
- unprofitable
Cocrystal Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $21.77M
- P/E
- unprofitable
Longeveron Inc.
Healthcare / Biotechnology
- Market Cap
- $21.71M
- P/E
- unprofitable
Retractable Technologies, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $21.28M
- P/E
- unprofitable
Cerenome, Inc.
Healthcare / Biotechnology
- Market Cap
- $20.91M
- P/E
- 1.0
Adial Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $20.89M
- P/E
- unprofitable
Dyadic International, Inc.
Healthcare / Biotechnology
- Market Cap
- $20.84M
- P/E
- unprofitable
Quantum BioPharma Ltd.
Healthcare / Biotechnology
- Market Cap
- $20.83M
- P/E
- unprofitable
Neuphoria Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $20.38M
- P/E
- unprofitable
Showing 901–950 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.